Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancersSuryatheja Ananthula, Wael M. ElShamy|Oncotarget|2016Cited by 22
<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:mi mathvariant="bold-italic">δ</mml:mi></mml:mrow></mml:math>-Tocotrienol Oxazine Derivative Antagonizes Mammary Tumor Cell Compensatory Response to CoCl<sub><b>2</b></sub>-Induced HypoxiaSuryatheja Ananthula, Paul W. Sylvester|BioMed Research International|2014Cited by 13
FDA Approval Summary: Vorasidenib for <i>IDH</i> -Mutant Grade 2 Astrocytoma or Oligodendroglioma Following SurgeryMichael I. Barbato, Nicole Drezner, Stephanie Aungst et al.|Clinical Cancer Research|2025Cited by 9